Next Article in Journal
Knowledge, Attitude, and Practice of Intranasal Corticosteroid in Allergic Rhinitis Patients: Development of a New Questionnaire
Previous Article in Journal
Exploring the Feelings of Nurses during Resuscitation—A Cross-Sectional Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Healthcare
Volume 10
Issue 1
10.3390/healthcare10010006
healthcare-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Acceptance of COVID-19 Vaccines among Patients with Inflammatory Bowel Disease in Japan

by
Yu Nishida
,
Shuhei Hosomi
*,
Yumie Kobayashi
,
Rieko Nakata
,
Masaki Ominami
,
Yuji Nadatani
,
Shusei Fukunaga
,
Koji Otani
,
Fumio Tanaka
,
Yasuaki Nagami
,
Koichi Taira
,
Noriko Kamata
and
Yasuhiro Fujiwara
Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan
*
Author to whom correspondence should be addressed.
Healthcare 2022, 10(1), 6; https://doi.org/10.3390/healthcare10010006
Submission received: 4 November 2021 / Revised: 16 December 2021 / Accepted: 17 December 2021 / Published: 22 December 2021
(This article belongs to the Topic Burden of COVID-19 in Different Countries)
Browse Figure
Versions Notes

Abstract

Coronavirus disease 2019 (COVID-19) vaccination is recommended for patients with inflammatory bowel disease (IBD). However, the acceptance of COVID-19 vaccines has not been sufficiently evaluated in patients with IBD. We aimed to assess the acceptance and hesitancy of COVID-19 vaccination and related factors among these patients. A retrospective cohort study using a self-reported questionnaire was performed among patients with IBD between 22 June 2021 and 30 August 2021. Of the 187 participants, 10.2% (n = 19) were hesitant to be vaccinated. Patients in the vaccine-hesitant group were younger (p = 0.009) and had a shorter disease duration (p = 0.020). Vedolizumab was prescribed more frequently (p = 0.024) and immunomodulators were less frequently used (p = 0.027) in this group. Multivariable logistic regression analysis identified age (odds ratio [OR]: 0.96, 95% confidence interval [CI]: 0.92–1.00, p = 0.042) and the use of immunomodulators (OR: 0.08, 95% CI: 0.01–0.66, p = 0.019) as independent significant factors for vaccine hesitancy. The COVID-19 vaccine hesitancy rate in patients with IBD in Japan was 10% in this study. The Japanese COVID-19 vaccination campaign appears to be successful. The risk of COVID-19 among patients with IBD requires adequate measures to ensure that vaccines are accepted by vaccine-hesitant patients. These findings may be helpful in achieving adequate vaccination rates.
Keywords: surveys and questionnaires; severe acute respiratory syndrome coronavirus 2; mRNA-1273; BNT162b2; AZD1222 surveys and questionnaires; severe acute respiratory syndrome coronavirus 2; mRNA-1273; BNT162b2; AZD1222

Share and Cite

MDPI and ACS Style

Nishida, Y.; Hosomi, S.; Kobayashi, Y.; Nakata, R.; Ominami, M.; Nadatani, Y.; Fukunaga, S.; Otani, K.; Tanaka, F.; Nagami, Y.; et al. Acceptance of COVID-19 Vaccines among Patients with Inflammatory Bowel Disease in Japan. Healthcare 2022, 10, 6. https://doi.org/10.3390/healthcare10010006

AMA Style

Nishida Y, Hosomi S, Kobayashi Y, Nakata R, Ominami M, Nadatani Y, Fukunaga S, Otani K, Tanaka F, Nagami Y, et al. Acceptance of COVID-19 Vaccines among Patients with Inflammatory Bowel Disease in Japan. Healthcare. 2022; 10(1):6. https://doi.org/10.3390/healthcare10010006

Chicago/Turabian Style

Nishida, Yu, Shuhei Hosomi, Yumie Kobayashi, Rieko Nakata, Masaki Ominami, Yuji Nadatani, Shusei Fukunaga, Koji Otani, Fumio Tanaka, Yasuaki Nagami, and et al. 2022. "Acceptance of COVID-19 Vaccines among Patients with Inflammatory Bowel Disease in Japan" Healthcare 10, no. 1: 6. https://doi.org/10.3390/healthcare10010006

APA Style

Nishida, Y., Hosomi, S., Kobayashi, Y., Nakata, R., Ominami, M., Nadatani, Y., Fukunaga, S., Otani, K., Tanaka, F., Nagami, Y., Taira, K., Kamata, N., & Fujiwara, Y. (2022). Acceptance of COVID-19 Vaccines among Patients with Inflammatory Bowel Disease in Japan. Healthcare, 10(1), 6. https://doi.org/10.3390/healthcare10010006

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop